L'intérêt à découvert pour Ubiquiti donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Ubiquiti. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Ubiquiti (NYSE:UI) Stock, Rapport sur les intérêts à découvert

UBIQUITI INC

Ubiquiti

Ubiquiti Inc is a wireless and wireline network equipment provider for small Internet service providers and small- and midsize-business integrators. Its product is based on two primary categories namely Service Provider Technology and Enterprise Technology. The company generates maximum revenue from Enterprise Technology. Geographically, it derives a majority of revenue from North America and also has a presence in Europe, the Middle East and Africa; Asia Pacific and South America.

Ubiquiti Inc

SINGAPORE LD GROUP LTD by SINGAPORE LD GROUP LTD

Singapore Land Group Ltd

SINGAPORE LD GRP U/ADR by SINGAPORE LD GROUP LTD

Unisys Corp

UTILICRAFT AEROSPACE INDS by Utilicraft Aerospace Industries, Inc.

Utilicraft Aerospace Industries Inc

VictoryShares Core Intermediate Bond ETF

VictoryShares International Value Momentum ETF

News

AMZN

Amazon CEO Jassy Says Seeing Significant Growth On Discretionary Items, Not Seeing Meaningful Impact From All The Noise Around Tariffs

WIIM

LOVE

Lovesac shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 and FY26 guidance with its midpoints above estimates.

Guidance

Amazon CEO Andy Jassy Says I Do Think That It's Possible This Environment Will Be A Little Bit Easier To To Start To Acquire

Truist Securities analyst Youssef Squali maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Buy and lowers the price target from $53 to $36.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Wayfair, Lowers Price Target to $36

LUCD

Lucid Dagnositcs shares are trading lower following a public offering of 12.5 million shares of common stock priced at $1.20 per share.

Truist Securities analyst Anthony Hau maintains Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) with a Buy and lowers the price target from $142 to $135.

Truist Securities Maintains Buy on Sun Communities, Lowers Price Target to $135

Amazon CEO Andy Jassy On Tariffs, Says: Too Early To See Change In Consumer Behavior; Says We're Going To Do Everything We Can To Keep Prices As Low As Are You Seeing; We Have Done Some Strategic Forward Inventory Buys

Truist Securities analyst Jailendra Singh maintains Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) with a Hold and lowers the price target from $347 to $333.

MEDP

Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $333

MRIN

Marin Software shares are trading lower after the company announced plans for dissolution, which its board of directors has approved.

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Buy and lowers the price target from $263 to $216.

Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216

Truist Securities analyst Jailendra Singh maintains Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) with a Buy and lowers the price target from $262 to $208.

ICLR

Truist Securities Maintains Buy on Icon, Lowers Price Target to $208

Microsoft Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has decided to suspend its billion-dollar data center project in Licking County, Ohio. ​This decision marks the most recent in a line of data center project cancellations by the software behemoth.
What Happened: Microsoft has backed out of its earlier commitment to invest $1 billion in three data center campuses located in New Albany, Heath, and Hebron. This decision aligns with the company&#8217;s recent trend of pulling out from data center projects across the US, Europe, APAC, and the U.K., <a href="https://www.dispatch.com/story/business/2025/04/07/microsoft-backs-out-of-plans-to-build-data-centers-in-licking-county/82973097007/">reported</a> The Columbus Dispatch.
The original plans, unveiled in October, involved a $420 million investment for the New Albany data center campus, which had been granted a 15-year tax abatement by the City Council. The data center was slated to occupy a 200-acre site with construction set to commence in July 2025.
A Microsoft spokesperson told the publication, &#8220;We will continue to evaluate these sites in line with our investment strategy.&#8221; The company also reaffirmed its plan to retain ownership of the land and proceed with development at a future date yet to be determined.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/equities/25/04/44728524/adam-schiff-and-elizabeth-warren-call-for-investigation-into-possible-insider-trading-by-trump-a" target="_blank" rel="noreferrer noopener">Adam Schiff And Elizabeth Warren Call For Investigation Into Possible Insider Trading By Trump Allies As Markets Surge After 90-Day Tariff Pause: &#8216;It Sure Looks Like Corruption&#8217;</a>
Why It Matters: This decision by Microsoft follows a pattern of similar project cancellations. Earlier this month, the tech giant had halted discussions and <a href="https://www.benzinga.com/news/global/25/04/44645946/microsoft-halts-data-center-expansions-due-to-semiconductor-tariff-concerns-ai-overcapacity-fears">postponed the development</a> of sites in several locations including the UK, Australia, and the U.S., due to concerns over semiconductor tariffs and AI overcapacity. 
Earlier in February, Microsoft <a href="https://www.benzinga.com/markets/25/02/43908921/microsoft-pulls-plug-on-ai-data-center-leases-says-analyst-oversupply-situation-likely">had begun to cance</a>l leases for a significant portion of its AI data center capacity in the U.S., hinting at a potential oversupply situation. ​TD Cowen&#8217;s analysts were the first to highlight the issue, speculating that lease cancellations and capacity deferrals indicate a data center oversupply relative to Microsoft&#8217;s current demand forecast. ​
Notably, in January, Microsoft unveiled plans to invest nearly $80 billion in developing AI-powered data centers and deploying AI and cloud-based applications globally.&nbsp;
Meanwhile, Noelle Walsh, Microsoft Cloud president, stated on LinkedIn that the company is on course to fulfill its capex commitment for the year, adding, &#8220;Data center planning is a multi-year and capital-intensive program&#8230; we are slowing or pausing some early-stage projects. While we may strategically pace our plans, we will continue to grow strongly and allocate investments that stay aligned with business priorities and customer demand.&#8221;
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/bonds/25/04/44729467/trump-didnt-just-flinch-he-ducked-on-tariff-pause-says-strategist-jessica-tarlov-argues-bond-market-forced-his-hand-amid-trillions-in-market-losses" target="_blank" rel="noreferrer noopener">Trump &#8216;Didn&#8217;t Just Flinch, He Ducked&#8217; On Tariff Pause, Says Strategist Jessica Tarlov: Argues Bond Market Forced His Hand Amid Trillions In Market Losses &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

MSFT

Microsoft Shelves $1 Billion Ohio Data Center Plans Amid Global Project Withdrawals: 'We Are Slowing Or Pausing Some Early-Stage Projects'

KROS

Keros Therapeutics shares are trading higher. The company announced that its board has initiated a formal review process to evaluate strategic alternatives to maximize shareholder value.

SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ("CUPR" or "the Company"), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary Shares ("the Offering"), all of which are being offered by CUPR at a public offering price of $4.00 per share ("the Offering Price").
The Company has granted the underwriter a 45-day option to purchase up to an additional 450,000 shares of its Class A Ordinary Shares at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering ("the Over-allotment").
Assuming that the Over-allotment is exercised, the Company is expected to receive gross proceeds amounting to $13.80 million, before deducting underwriting discounts and commissions and estimated offering expenses.
The shares are expected to begin trading on the NASDAQ Stock Market LLC under the ticker symbol "CUPR" on April 10, 2025. The Offering is expected to close on April 11, 2025, subject to the satisfaction of customary closing conditions.

IPOs

CUPR

Cuprina Holdings Prices IPO of 3,000,000 shares of Class A Ordinary Shares at $4.00/Shr; To Commence Trade On Apr 10 Under Ticker CUPR

Renowned economist Peter Schiff has delivered a scathing assessment of President Donald Trump&#8216;s recent tariff policy, comparing the rollout and the subsequent pause to the catastrophic failure of the 1937 Hindenburg airship disaster.
What Happened: In a post on X post, Schiff argued that Trump's aggressive tariff threats have backfired, exposing vulnerabilities in the U.S. economy and diminishing his negotiating power on the global stage.
Schiff&#8217;s critique highlights the potential consequences of Trump&#8217;s aggressive trade tactics. By implementing sweeping tariffs and then abruptly pausing them, Trump may have signaled to trading partners that his threats are not as credible as initially perceived. This perceived weakness could undermine his negotiating position in future trade talks.
&#8220;Trump reduced himself to a paper tiger,&#8221; added Schiff.
He characterized Trump's tariff rollout as highly flawed, likening it to the "Hindenburg of trial balloons" — a metaphor referencing the 1937 airship disaster that marked a dramatic and tragic end to an era.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If Trump really wanted to use the threat of tariffs to negotiate deals, he substantially weakened his bargaining position by demonstrating how much damage the U.S. would suffer by imposing them. By floating the Hindenburg of trial balloons, Trump reduced himself to a paper tiger.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1910274090679623897?ref_src=twsrc%5Etfw">April 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/04/44728276/spy-qqq-call-volumes-spiked-minutes-before-tariff-pause-announcement-alexandria-ocasio-cortez-demands-disclosure-from-congress-members">SPY, QQQ Call Volumes Spiked Minutes Before Tariff Pause Announcement: Alexandria Ocasio-Cortez Demands Disclosure From Congress Members</a>
Why It Matters: The U.S. stock market recovered on Wednesday after Trump paused the tariffs, with the S&amp;P 500 logging its largest single-day gain since 2008. It was also the S&amp;P 500&#8217;s third-biggest one-day gain since 1950.
Bill Ackman, billionaire investor and Pershing Square CEO, <a href="https://www.benzinga.com/news/global/25/04/44723751/billionaire-investor-bill-ackman-praises-trumps-tariff-pause-thank-you-on-behalf-of-all-americans">applauded President Trump&#8217;s 90-day tariff pause</a> for non-retaliating nations, while Trump simultaneously increased tariffs on China to 125%. Ackman expressed his gratitude on X, particularly praising Treasury Secretary Scott Bessent. 
Ray Dalio, the billionaire founder of Bridgewater Associates, <a href="https://www.benzinga.com/25/04/44727235/how-wall-street-and-tech-leaders-reacted-to-trumps-surprise-tariff-stance-reversal">lauded Trump&#8217;s pivot towards trade negotiations</a> over escalating tensions as &#8220;a much better way&#8221; in an X post. He urged the President to secure a deal with China and lower the fiscal deficit to 3% of GDP, suggesting a strategy involving RMB appreciation against the dollar via China selling dollar assets and easing its economic policies to boost demand. 
Notably, the Nasdaq 100 rose to exit the bear territory and was down 13.85% from its previous record of 22,222.61 points. The S&amp;P 500 was still in the correction zone, down 11.23% from its last high of 6,147.43 points. Whereas Dow Jones was 9.91% lower than its 52-week high of 45,073.63 points.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Thursday. The SPY was down 2.75% to $533.51, while the QQQ declined 2.49% to $454.41, while the QQQ declined 1.81% to $457.56, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pr</a>o data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44730455/bearish-sentiment-hits-7-week-high-mimicking-35-year-old-record-which-marked-the-bottom-of-the-october-1990-bear-market">Bearish Sentiment Hits 7-Week High, Mimicking 35-Year Old Record Which Marked The Bottom Of The October 1990 Bear Market</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock

Analyst Color

Equities

Government

Macro Economic Events

Macro Notification

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

Economics

ETFs

General

Donald Trump 'Reduced Himself To A Paper Tiger,' Says Peter Schiff After Comparing Tariff Rollout And Pause To The 'Hindenburg Of Trial Balloons'

The global drone inspection and monitoring market is projected to reach $21.3 billion by 2027, driven by demand in industries such as oil and gas, mining, critical infrastructure, and manufacturing. Revenues from the commercialization of the jointly developed technology may reach up to $32 million by 2031&nbsp;

FRSX

Foresight Autonomous Holdings And Indian Drone Manufacturer Sign MOU For Autonomous Industrial Drones Project

Spruce Power Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) ("Spruce" or the "Company") today announced the signing of a new Spruce Pro servicing partnership with commercial &amp; industrial ("C&amp;I") and residential solar installer Hot Purple Energy ("Hot Purple") to monetize Solar Renewable Energy Credits ("SREC") in California.
This partnership is part of a broader Spruce initiative to leverage the Company's platform and experience to capture the unrealized benefit of SREC credits for installers and C&amp;I operators. As part of this agreement, Spruce will be responsible for initial and ongoing registration and monetization of Hot Purple's SRECs with the Western Renewable Energy Generation Information System ("WREGIS"). The Company will also manage the monthly reporting of production and sale of SRECs for Hot Purple's solar generation assets, generating cash flow for both Spruce and Hot Purple.

Spruce Power Holding Corporation Class A Common Stock

SPRU

Spruce Power Partners With Hot Purple Energy To Monetize California Solar Renewable Energy Credits Through New Spruce Pro Servicing Agreement

<ul>
<li>Latest granted patents reinforce Pluri's position as a leader in Mucosal-Associated Invariant T ("MAIT") cell-based cell therapies for solid cancers</li>
<li>Pluri's MAIT platform&nbsp;enables commercial scale production of powerful immune cells as a potential first-in-class, ready to use, "off-the-shelf" therapy for cancer patients</li>
<li>Pluri's MAIT platform addresses the global immune cell engineering market, projected to reach approximately <a href="https://www.coherentmarketinsights.com/industry-reports/immune-cell-engineering-market">$11.7 billion</a> by 2030, and the global cancer immunotherapy market, calculated at <a href="https://www.precedenceresearch.com/cancer-immunotherapy-market">$136 billion</a> in 2025</li>
<li>In addition to MAIT cells, Pluri's platform also supports the expansion of Tumor Infiltrating Lymphocytes (TILs), further broadening the scope of potential immune cell therapies in cancer immunotherapy and attracting attention in the growing TILs-focused research space</li>
</ul>
HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUR#NASDAQ">PLUR</a>) (TASE: PLUR) ("Pluri" or the "Company"), a biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a patent covering the Company's immune cell expansion technologies. This patent specifically includes MAIT cells, a unique subset of T cells that are crucial in helping the body fight infection and repair tissue. Additionally, Pluri was issued a patent in Israel, which mirrors <a href="https://www.globenewswire.com/Tracker?data=bvxrmbKy74-S13UGLTkd4kX7U-QzrXEjMf-GRyHgAF10llsatejhI1AydY4zUJi3fCWwwrMLjVsErMqB1igi9HUwIPeuCrtrWpvgn3hiVBFgbW9NWn6gBqVUwrnhkgNUCEPpEDYXDw1PZbQEoufdIdcDfbcpI2S2EfawDqqMDv1ZdqSctxAH_qDPxLJ8eYhWt8e63lbmIKZeA9Rzkw5mFim3BK_Y3nIJ-2CPuXaTtNg=">previously granted US patent</a>. Pluri's total intellectual property ("IP") estate now includes over 250 patents pending, allowed, and granted.
<a href="https://www.globenewswire.com/Tracker?data=TgF75h7t_fxOGpuWWzHQCexKTlMFVEHw9f3xbxPA-YH0w7udswDbdCpM7P3rqWbkAdFh8SK7N4bbNhMzWx-S2ka6WsOWCoSOx-3_wlrgkj0b-LjeVXBYBEHw-gcwjWsl">Pluri's p</a><a href="https://www.globenewswire.com/Tracker?data=VXkISd1WE7wWCaFyS7bcNXE09r8kMFcWiF3Zr2jtChDnBB-aL6G-WHF49muwngLLfzuTjTDv0S1OaASE1zAZ_EBSLKSXwigbk4lVoBO-8l51vhw1fqTOvhA1UMZxepem">lacental MAIT cells</a> are unique, unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical need. MAIT cells offer unique advantages compared to conventional T cells, holding immense potential for immunotherapy, but until now, their expansion has been a challenge, primarily due to the difficulty in expanding them outside of the human body. Leveraging two decades of cell expertise, Pluri believes that it has overcome the challenge to unlock the full potential of MAIT cells.
The granted patents titled "System and Methods For Immune Cells Expansion and Activation In Large Scale" focus on a system and method for culturing and/or activating immune cells in a large scale, within Pluri's proprietary 3D cell expansion bioreactors.
"These latest granted patents, which further fortify our growing IP around MAIT cells, are very timely as the U.S. Food and Drug Administration has recently approved Tumor-infiltrating lymphocytes (TILs) and T Cell Receptor-engineered T cell (TCR-T) therapies for the treatment of solid cancers. We believe that MAIT cells represent an emerging field with significant potential in immunotherapy and we believe that our unmatched ability to scale production of MAIT cells, combined with our growing IP portfolio, position Pluri for collaborations that can potentially deliver immune therapies to people in need," stated Yaky Yanay, Chief Executive Officer and President of Pluri. "We foresee the potential to further develop and bring to market our own proprietary placental-derived MAIT cell immunotherapy platform to revolutionize solid tumor treatment, as well as supporting others in commercializing their immunotherapy treatments."

Biotech

PLUR

Pluri Announces That U.S. Patent And Trademark Office Has Issued Patent Covering The Company's Immune Cell Expansion Technologies

CNDT

CORRECTION: Conduit Pharmaceuticals Ticker Is 'CDT'

Enact Holdings shares are trading higher after the company announced it's set to join the S&P SmallCap 600 on April 16.

Press Releases

Ubiquiti Inc. Reports Third Quarter Fiscal 2024 Financial Results

Ubiquiti Inc. Reports Fourth Quarter Fiscal 2024 Financial Results

HyperLight Accelerates Growth With $37M Funding Led by Summit Partners

Peraso Inc. (NASDAQ: PRSO) Driving 5G Innovation Across Multiple Industries more stock inside…

Ubiquiti Inc. Reports First Quarter Fiscal 2025 Financial Results

Ubiquiti Inc. Reports Second Quarter Fiscal 2025 Financial Results

ANET

BLMZ

CRKN

MTSI

PRSO

SRFM

Applied Optoelectronics, Inc. - Common Stock

Applied Optoelectronics

Adtran Holdings

Arista Networks

Aviat Networks

Calix

Ciena

Clearfield

CommScope Holding Company, Inc. - Common Stock

CommScope Holding Co

Cisco Systems

Digi Intl

Ericsson - American Depositary Shares each representing 1 underlying Class B share

Comments

Ubiquiti

Intérêt court

Ubiquiti (NYSE:UI) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL